SEC Filings

8-K
PERNIX THERAPEUTICS HOLDINGS, INC. filed this Form 8-K on 02/27/2019
Entire Document
 

Schedule 4.5

 

Intellectual Property

 

Pernix Therapeutics, LLC

 

Patents
Title Country Status Patent No. Appl. No Issue Date
Process for preparing tannate liquid and semi-solid dosage forms US Issued 7,094,429 10/921,438 08/22/2006
Process for preparing tannate tablet, capsule or other solid dosage forms US Issued 7,273,623

10/269,027

 

09/25/2007
Tannate compositions, methods of making and methods of use US Issued 8,012,506 11/501,649 09/06/2011

 

Trademarks
Mark Country Status Serial No. Reg. No. Reg. Date
US Registered 85251109 4076351 12/27/2011
KR Registered 40-2017-0120858 40-1419740 11/22/2018
Pernix US Registered 77779507 3897832 12/28/2010
PRESCRIPTIONS DIRECT US Registered 86757098 5024315 8/22/2016
Pediatex US Registered 75775487 2684051 04/04/2003
US Registered 78176952 2764357 09/16/2003
Aldex US Registered 78126667 2748943 08/05/2003
Z-Cof US Registered 76258253 2738086 07/15/2003

 

Gaine, Inc (“Gaine”).

 

Patents
Title Country Status Patent No. Appl. No Issue Date
Antitussive compositions US Issued/expired 6348470 09/381,841 02/19/2002

Schedule 4.5

Page - 1